APA (7th ed.) Citation

O, M., E, C., E, D., AM, M., C, C., AM, B., . . . H, W. (2015). Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL. Leukemia, 29(1), 107. https://doi.org/10.1038/leu.2014.146

Chicago Style (17th ed.) Citation

O, Middleton, Cosimo E, Dobbin E, McCaig AM, Clarke C, Brant AM, Leach MT, Michie AM, and Wheadon H. "Complement Deficiencies Limit CD20 Monoclonal Antibody Treatment Efficacy in CLL." Leukemia 29, no. 1 (2015): 107. https://doi.org/10.1038/leu.2014.146.

MLA (9th ed.) Citation

O, Middleton, et al. "Complement Deficiencies Limit CD20 Monoclonal Antibody Treatment Efficacy in CLL." Leukemia, vol. 29, no. 1, 2015, p. 107, https://doi.org/10.1038/leu.2014.146.